Condition

Hodgkin's Lymphoma

ClinicalTrials.gov condition label

Clinical trials9
Recruiting1
Common interventions13
Lead sponsors shown8

Clinical trials

9 shown
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaNCT01788839 · 2013-02-01
RECRUITING
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare CancersNCT05337735 · 2022-08-05
SUSPENDED
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesNCT02223052 · 2014-10-27
COMPLETED
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced MalignanciesNCT01929941 · 2013-09-01
TERMINATED
Low Dose Chest Computed Tomography (CT) ScreeningNCT01180010 · 2010-08-01
COMPLETED
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumNCT00896454 · 2009-11-16
COMPLETED
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell TransplantNCT00510315 · 2007-07-01
COMPLETED
Nonmyeloablative Allogeneic TransplantNCT01272817 · 2001-10-01
COMPLETED
Prospective Study of Lymphoproliferative DiseasesNCT01704742
WITHDRAWN

Trial status mix

COMPLETED5
RECRUITING1
SUSPENDED1
TERMINATED1
WITHDRAWN1

Phase mix

PHASE12
PHASE22
NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.